Search Now


Friday, March 10, 2006

Reliance Communicatin Ventures - NetworthStock

Download here

Sharekhan Investor's Eye

Cluster: Apple Green
Recommendation: Buy
Price target: Rs1,130
Current market price: Rs960

Making the right decisions

The recent events relating to Lupin are as follows:

  1. a joint venture with Aspen Pharmacare Holdings, South Africa,
  • request for conducting clinical trials of new anti-tuberculosis (TB) molecule,
  • the divestment of its stake in its Thai subsidiary,
  • the discontinuation of its Suprax marketing deal with Cornerstone and
  • the deal with Chester Valley Pharmaceuticals.
  • These are clear indications of the increased focus of the company on the high-revenue, high-margin regulated markets. We believe these events are important and pave the way for growth of the company in the future.